Cerus Corporation

CERS Healthcare Medical Devices

Revenue
+6.28%
EPS
−2,800.0%
Free cash flow
+2,471.3%
Total debt
−25.4%

Quarter to September 2026, against a year earlier

2.03 0.10 −4.69%
Market cap
$430.2M
P/E
0.0×
Fwd P/E
−65.1×
Dividend yield
—
F-score
5/9
Altman Z
−4.00
Beneish M
−2.87
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Piotroski F-Score
4 4 5 3 5 3 4 4 5 5
P/S ratio
11.23 7.51 8.78 6.29 9.93 7.31 3.51 2.08 1.41 1.68
Altman Z-Score
(3.92) (7.17) (1.55) (4.12) 0.35 (0.54) (3.24) (4.87) (4.94) (4.00)
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 52.87 0.00 33.35 354.35
Altman Z″-Score (non-manufacturers)
(19.22) (22.72) (12.89) (15.80) (10.58) (11.03) (14.03) (15.30) (14.46) (13.54)
Beneish M-Score
(2.82) (2.44) (3.05) (1.34) (2.66) (2.51) (2.52) (2.22) (3.35) (2.87)
P/Operating CF
(45.40) (38.39) (94.08) (71.77) (127.46) (954.51) (376.01) (25.65) 57.66 63.33
P/B ratio
7.63 9.89 7.90 10.34 10.93 13.62 9.63 7.29 5.00 6.04
EV/Sales
9.90 7.01 7.62 5.85 9.18 6.94 3.33 2.16 1.43 1.68
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/FCF
(7.18) (6.84) (17.90) (7.37) (24.16) (31.77) 50.28 (8.44) 33.79 355.26
Current Ratio
3.50 3.89 2.79 2.55 3.06 2.38 1.45 2.14 2.39 1.73
Net Debt/EBITDA
0.88 0.55 1.64 0.65 1.55 1.31 1.04 (0.51) (0.30) (0.14)
Debt/Equity
0.34 0.77 0.35 0.78 0.46 0.81 1.02 1.49 1.48 1.29
ROE
(82.47%) (125.27%) (93.25%) (100.65%) (74.42%) (57.41%) (55.49%) (61.45%) (37.92%) (25.65%)
ROA
(51.80%) (60.07%) (43.99%) (43.31%) (30.94%) (23.70%) (18.78%) (18.03%) (10.49%) (7.39%)
ROIC
(693.97%) (447.11%) 0.00% (262.55%) (199.05%) (119.11%) (58.82%) (27.87%) (14.67%) (8.22%)
Return on Tangible Assets
(89.61%) (87.95%) (56.24%) (76.88%) (43.59%) (45.03%) (66.78%) (43.82%) (21.89%) (18.88%)
Average Days of Receivables
63.83 88.29 42.00 65.71 67.62 57.50 66.73 69.37 53.99 47.42
Earnings Yield
(14.32%) (15.73%) (8.68%) (12.32%) (5.20%) (4.55%) (6.68%) (9.58%) (7.08%) (3.89%)
Free Cash Flow Yield
(12.27%) (13.65%) (4.85%) (12.61%) (3.83%) (2.99%) 1.89% (12.27%) 3.00% 0.28%
Free Cash Flow per Share
(0.53) (0.49) (0.25) (0.53) (0.26) (0.20) 0.07 (0.26) 0.05 0.01
Book value per Share
0.57 0.36 0.64 0.41 0.63 0.50 0.39 0.30 0.31 0.34
Free Cash Flow
(54.09) (52.59) (32.39) (74.43) (43.43) (34.83) 12.49 (47.76) 8.52 1.11
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026